ESMO Targeted Anticancer Therapies Asia Congress

ESMO TAT, the multi-stakeholder forum gathering key actors in cancer drug development, arrives in one of the most dynamic and best-connected hubs in Asia, making the latest advances in early clinical trials accessible to everyone in the region. Through in-depth discussions on critical topics such as innovation, digital transformation, research methodology, business insights, regulation, and public policy, ESMO TAT Asia aims to drive progress in cancer treatment and research.

Located in the lively city of Hong Kong, ESMO TAT Asia promises to be a vibrant gathering with region’s industry, academia, clinicians, and regulators to promote international cooperation and accelerate the anticancer research.

Come and join us to chart new paths in cancer drug development in Asia.

Abstract submission deadline: 29 April 2025
Early Registration until: 14 May 2025
Late Registration until: 18 June 2025